メルク・KGaAは予想を上回り10%の利益成長率を上げ,EBITDA見通しを上げ,生命科学,医療,電子機器の需要が強くなった. Merck KGaA beat forecasts with 10% profit growth and raised EBITDA outlook, fueled by strong demand in life sciences, healthcare, and electronics.

メルクKGaAは,ライフサイエンス,ヘルスケア,電子機器の需要により,税別利益が898百万ユーロ (1.04億米ドル) に10%増加し,EBITDAの8.8%の有機成長で,第3四半期業績がより堅調であったと報告した. Merck KGaA reported stronger third-quarter results with a 10% rise in after-tax profit to 898 million euros ($1.04 billion) and 8.8% organic EBITDA growth, driven by demand in life sciences, healthcare, and electronics. 売上高は5.32億ユーロに5.2%増加し,分析家の予測を上回った. Net sales rose 5.2% organically to 5.32 billion euros, surpassing analyst forecasts. 同社は全年度の視野を狭め,3%の有機販売の成長目標を維持し,EBITDAの成長ガイドを5%に調整し,以前から2%から4%-48%までの範囲を増加させた. The company narrowed its full-year outlook, maintaining a 3% organic sales growth target and adjusting EBITDA growth guidance to 5%–7%, up from earlier 2%–5% and 4%–8% ranges.